COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Eric Linsley will co-chair the CED's 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
